Why Is Amoxicillin/Vonoprazan So Hard to Find? [Explained for 2026]

You've been diagnosed with H. pylori — one of the most common bacterial infections in the world — and your doctor has prescribed Amoxicillin/Vonoprazan (brand name Voquezna Dual Pak). But when you call your pharmacy, they tell you it's not in stock. Sound familiar?

You're not alone. Patients across the U.S. are discovering that this highly effective H. pylori treatment is surprisingly difficult to find at their local pharmacy. Here's why — and what you can do about it.

What Is Amoxicillin/Vonoprazan (Voquezna Dual Pak)?

Amoxicillin/Vonoprazan is a co-packaged prescription drug sold under the brand name Voquezna Dual Pak, made by Phathom Pharmaceuticals. It combines two medications: vonoprazan (a first-in-class potassium-competitive acid blocker, or PCAB) and amoxicillin (a penicillin antibiotic). Together, they work to eradicate Helicobacter pylori (H. pylori) bacteria in the stomach.

The FDA approved Voquezna Dual Pak in May 2022, but the medication didn't reach pharmacy shelves until December 2023. That delayed launch — combined with the fact that this is an exclusively branded product with no generic equivalent — is part of why filling a prescription can be a challenge.

Is There an Official Shortage of Amoxicillin/Vonoprazan?

No. As of 2026, Amoxicillin/Vonoprazan (Voquezna Dual Pak) is not listed on the FDA's official Drug Shortage Database. This means there is no manufacturer-level supply problem comparable to what amoxicillin oral suspension experienced in 2022–2024.

However, "not in an FDA shortage" doesn't mean "easy to find at your local pharmacy." Many patients still run into stocking gaps for a different set of reasons.

Why Is Voquezna Dual Pak Hard to Find at Pharmacies?

Several factors combine to make this medication less universally available than a common drug like amoxicillin or omeprazole:

• It's a new drug. Voquezna Dual Pak only became available in U.S. pharmacies in December 2023. Pharmacies are still building routine stocking patterns for it.
• It's brand-only. There is currently no generic version of Voquezna Dual Pak. Pharmacies prioritize shelf space for high-volume generics. A brand-only specialty product may only be stocked at select locations or ordered on demand.
• It has a higher cost. At $835–$1,014 per 14-day course, the cash price is steep. Some pharmacies may be reluctant to keep large quantities in stock due to carrying costs.
• Insurance prior authorization creates delays. Many insurance plans list Voquezna Dual Pak as Tier 3 or Tier 4 and may require prior authorization before covering it. This adds processing time before a pharmacy will even order it.
• Prescribers sometimes choose alternatives first. Some prescribers default to bismuth quadruple therapy or generic components, which reduces overall demand for the combination pack and limits how widely pharmacies stock it.

Which Pharmacies Are Most Likely to Have Amoxicillin/Vonoprazan in Stock?

Large chain pharmacies — including CVS, Walgreens, and Walmart Pharmacy — are the most likely to carry Voquezna Dual Pak, because they have the purchasing volume and inventory infrastructure to stock newer branded drugs. Hospital outpatient pharmacies and specialty pharmacies are also reliable sources.

Small independent pharmacies may not stock it routinely and may need to order it from their wholesaler — a process that can take 1–3 business days.

Does Insurance Coverage Affect Availability?

Yes. Insurance tier placement and prior authorization requirements directly affect whether your pharmacy will stock Amoxicillin/Vonoprazan for routine dispensing. If a plan in a given area doesn't cover it without prior auth, the pharmacy may not bother carrying it in inventory.

If your insurance requires prior authorization, work with your doctor to submit it as quickly as possible. Phathom Pharmaceuticals also offers a Voquezna Savings Card for commercially insured patients that can lower cost to as little as $25 per fill — but this is not available to Medicare or Medicaid recipients.

What Should You Do If You Can't Find Amoxicillin/Vonoprazan?

Here are your best options:

1. Use medfinder. medfinder.com calls pharmacies near you to check which ones actually have your medication in stock — saving you hours of calling around yourself.
2. Call chain pharmacies first. CVS, Walgreens, Walmart Pharmacy, and Rite Aid are more likely to carry Voquezna Dual Pak than independent pharmacies.
3. Ask about specialty or mail-order pharmacies. Your insurance may have a preferred mail-order pharmacy that can ship Voquezna Dual Pak directly to your home.
4. Talk to your doctor about alternatives. If you're unable to fill Voquezna Dual Pak, your provider may be able to prescribe bismuth quadruple therapy (generic, ~$30–$80), rifabutin triple therapy (Talicia), or Voquezna Triple Pak instead.

How Important Is It to Treat H. pylori Quickly?

H. pylori infection is linked to peptic ulcers, chronic gastritis, and — if left untreated long-term — an increased risk of gastric cancer. While a few days of delay filling a prescription is unlikely to cause serious harm, you should not leave H. pylori untreated for weeks. If you cannot find Amoxicillin/Vonoprazan within a few days, contact your doctor to discuss the fastest available alternative.

The Bottom Line

Amoxicillin/Vonoprazan (Voquezna Dual Pak) isn't in an FDA shortage, but its newness, brand-only status, and high cost make it spottily available across U.S. pharmacies in 2026. Your best approach is to search broadly — using medfinder or by calling multiple chain pharmacies — and to act quickly so your H. pylori treatment isn't delayed. See also: How to find Amoxicillin/Vonoprazan in stock near you.